Otsuka and Sunovion Initiate Clinical Development of Ulotaront for the Adjunctive Treatment of Major Depressive Disorder - Business Wire

Submitted by Anonymous (not verified) on Thu, 12/01/2022 - 14:00

Otsuka and Sunovion Initiate Clinical Development of Ulotaront for the Adjunctive Treatment of Major Depressive Disorder  Business Wire